Statement was made by Dr Kauffmann (Boston Children's Hospital) bottom of pg 1 in italics.
I totally agree, the whole Autism spectrum is in play here, but will need the resources of Big Pharma to start trials in all the various potential applications. I am hoping Neuren does a licencing deal with royalties because the potential is so huge. But if I was Big Pharma I would be looking to buy them outright (cheap) and maximise the potential myself.
Importance of the trial results & challenges, page-6
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.33 |
Change
-0.480(3.48%) |
Mkt cap ! $1.703B | |||
| Open | High | Low | Value | Volume |
| $13.82 | $13.91 | $13.32 | $4.989M | 369.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.41 | 1680 | 2 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |